SYNTAX Score 2020 vs KAK
Price, ratings, monetisation and update history for both apps, side by side โ with what reviewers say about each.
SYNTAX Score 2020
Read full descriptionHide full description
The SYNTAX Score 2020 guides the individual treatment decision making between PCI and CABG for patients having three-vessel disease with/without left main on the basis of 5 years MACCE and 10 years all-cause mortality. The SYNTAX Score 2020 and its derived variants intend to provide therapeutic advice or guidance as to appropriate treatment strategies for individual patients. Their major features are ANATOMIC SYNTAX SCORE LOGISTIC CLINICAL SYNTAX SCORE (2020) SYNTAX SCORE III (PCI & CABG DECISION-MAKING) FUNCTIONAL SYNTAX SCORE SYNTAX SCORE II (PCI & CABG DECISION-MAKING) SYNTAX SCORE III (PLANNING & EXECUTION CABG) SYNTAX Score 2020
KAK
Read full descriptionHide full description
Quick risk-calculator for contrast-induced nephropathy based on validated clinical model KAK-CIN Score is a clinical decision-support tool designed to help healthcare professionals estimate the probability of Contrast-Induced Nephropathy (CIN) in patients who will receive intravascular contrast medium. The algorithm is based on the peer-reviewed study by Kulkarni et al (Indian Journal of Nephrology, 2023) which derived and validated a simplified risk score system. Key features: Input four key patient variables: Estimated Glomerular Filtration Rate (eGFR) Contrast volume (mL) Route of contrast administration (arterial vs intravenous) Presence or absence of Diabetes Mellitus Instantly calculates a risk-percentage for CIN and provides a risk category (e.g., low, moderate, high) and provides the CIN Score. Published Journal: https://indianjnephrol.org/?view-pdf=1&embedded=true&article=af81b65b1e790875fb17d4a368ca9457Aplh7GbponE%3D Why use KAK-CIN Score? The original study included 1,300 patients (derivation 1,000 + validation 300) with an observed incidence of CIN of 3.8 %. The model showed high sensitivity (90.4 %) and specificity (98.8 %) in the validation cohort. Unlike many prior CIN risk models that were limited to cardiac catheterisation, this score covers both intra-arterial and intravenous contrast exposure. Important disclaimer This app is for educational and decision-support purposes only. It does not replace clinical judgement, institutional protocols or specialist consultation. Use results in conjunction with the full clinical context. The authors are not responsible for any clinical outcomes resulting from use of this tool. Always follow local guidelines. Privacy & Security No patient-identifiable data is stored beyond your device.
Screenshots
Verdict
The clearest difference is update cadence: KAK at fortnightly against SYNTAX Score 2020's every 6 weeks. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price ยท Rating ยท Positive reviews ยท Number of ratings ยท Update frequency ยท Ads ยท In-app purchases ยท Monetization ยท Best chart rank ยท Devices ยท Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
SYNTAX Score 2020 ships an update every 6 weeks, KAK fortnightly. The most recent releases landed on October 5, 2026 and October 15, 2026 respectively.
| Parameter | SYNTAX Score 2020 | KAK |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 6 weeks | Fortnightly โ better |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 12.0 โ better | 13.0 |
| Further details โ not scored | ||
| Size | 50 MB | 20 MB |
| Age rating | 17+ | 4+ |
| Developer | SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED | Mehulkumar Thakkar |
In-app purchases
SYNTAX Score 2020
No in-app purchases
KAK
No in-app purchases
Questions
Is SYNTAX Score 2020 free?
Is KAK free?
Do SYNTAX Score 2020 or KAK have ads?
Which is updated more often, SYNTAX Score 2020 or KAK?
Other comparisons















